Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12861/jrip.2015.23 http://scihub22266oqcxt.onion/10.12861/jrip.2015.23 C4685979!4685979!26693496     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Renal+Inj+Prev 2015 ; 4 (4): 109-12 Nephropedia Template TP {{tp|p=26693496|t=2015. Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy |pdf=|usr=}}{{26693496}} gab.com Text Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy JO: J Renal Inj Prev http://www.kidney.de/pget.php?&tw=1&pmid=26693496 #FOAvip Introduction: Intravenous contrast agents can cause acute decline in kidney function, especially in patients with risk factors. Objectives: In this study, we aimed to examine the ameliorative effect N-acetylcysteine (NAC) to reduce the incidence of contrast nephropathy. Patients and Methods: This study was a prospective, randomized, double-blind clinical trial on 150 patients who underwent coronary angiography. The study was carried out on patients undergoing coronary angiography. Patients were randomly assigned into 2 groups of intervention group and control subjects. Intervention group took NAC 600 mg orally twice a day. It was administered one day before angiography and continued until the second day after angiography. Control subjects received saline only. Serum creatinine was measured before and three days after coronary angiography. Results: There was no significant difference between intervention and control groups at baseline (P > 0.05). However, there was a significant decline in creatinine level among NAC patients (P = 0.001). Saline group had significantly higher proportion of nephropathy cases than NAC patients Conclusion: We found that the consumption of NAC is useful for contrast induced nephropathy (CIN) prevention. Twit Text FOAVip Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy ????J Renal Inj Prev http://www.kidney.de/pget.php?&tw=1&pmid=26693496 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26693496 #FOAvip English Wikipedia <ref>{{Cite pmid|26693496}}</ref> Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy #MMPMID26693496 Pezeshgi A; Parsamanesh N; Farhood G; Mahmoodi K J Renal Inj Prev 2015[]; 4 (4): 109-12 PMID26693496show ga Introduction: Intravenous contrast agents can cause acute decline in kidney function, especially in patients with risk factors. Objectives: In this study, we aimed to examine the ameliorative effect N-acetylcysteine (NAC) to reduce the incidence of contrast nephropathy. Patients and Methods: This study was a prospective, randomized, double-blind clinical trial on 150 patients who underwent coronary angiography. The study was carried out on patients undergoing coronary angiography. Patients were randomly assigned into 2 groups of intervention group and control subjects. Intervention group took NAC 600 mg orally twice a day. It was administered one day before angiography and continued until the second day after angiography. Control subjects received saline only. Serum creatinine was measured before and three days after coronary angiography. Results: There was no significant difference between intervention and control groups at baseline (P > 0.05). However, there was a significant decline in creatinine level among NAC patients (P = 0.001). Saline group had significantly higher proportion of nephropathy cases than NAC patients Conclusion: We found that the consumption of NAC is useful for contrast induced nephropathy (CIN) prevention. äEvaluation of the protective effect of N-acetylcysteine on contrast me(epmc).pdf DeepDyve Pubget Overpricing